Shuanglu Pharmaceutical: The long-acting and short-acting follicle-stimulating hormone developed by the company is currently in clinical phase II and III, and it is expected to submit registration applications within one or two years.

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

002038 002913 300713 Aoshikang Technology Beijing Sl Pharmaceutical Shenzhenrease Technology Science, Technology Pharmaceutical Financial, Business Service Paper, Packaging Product Currency Espionage, Intelligence Technology, Engineering Marriage Series Economy, Business, Finance

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Shuanglu Pharmaceutical: The long-acting and short-acting follicle-stimulating hormone developed by the company is currently in clinical phase II and III, and it is expected to submit registration applications within one or two years.